New Pfizer-BioNTech Covid Vaccine Is More Effective Than The Original, Study Shows

Pfizer-BioNTech’s new bivalent Covid-19 vaccine—which targets the original strain and some Omicron subvariants—provides more protection against the virus and its omicron variants than its initial vaccine, according to a study released Friday.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive